Published in Ann Rheum Dis on March 01, 1991
Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis (1995) 1.46
Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis (1994) 0.99
Influence of hypoxia in inflammatory synovitis. Ann Rheum Dis (1998) 0.98
Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression. Osteoarthritis Cartilage (2014) 0.81
2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts. Ann Rheum Dis (1995) 0.75
Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med (1985) 11.68
The specific interaction of hyaluronic acid with cartillage proteoglycans. Biochim Biophys Acta (1972) 4.44
Angiogenesis induced by degradation products of hyaluronic acid. Science (1985) 3.37
Intra-articular pressure in rheumatoid arthritis of the knee. I. Pressure changes during passive joint distension. Ann Rheum Dis (1970) 2.96
Oxidants and human disease: some new concepts. FASEB J (1987) 2.60
Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum (1967) 2.23
Oxygen tension in synovial fluids. Arthritis Rheum (1971) 2.14
Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis (1985) 2.14
Hypoxic-reperfusion injury in the inflamed human joint. Lancet (1989) 2.11
The hyaluronate receptor is associated with actin filaments. J Cell Biol (1987) 1.85
Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest (1985) 1.70
Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology (1980) 1.67
Respiratory gases of synovial fluids. An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis. Am J Med (1970) 1.65
Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1984) 1.61
Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid. Biochem Biophys Res Commun (1980) 1.56
Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40-transformed 3T3 cells. J Biol Chem (1983) 1.52
Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest (1985) 1.51
Methanol poisoning in human subjects. Role for formic acid accumulation in the metabolic acidosis. Am J Med (1980) 1.49
Is chronic synovitis an example of reperfusion injury? Ann Rheum Dis (1986) 1.45
Nomenclature of hyaluronic acid. Biochem J (1986) 1.45
Methanol poisoning: ocular toxicity produced by formate. Toxicol Appl Pharmacol (1978) 1.42
Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis (1985) 1.41
Rheology of hyaluronic acid. Biopolymers (1968) 1.41
Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status. Ann Rheum Dis (1989) 1.40
Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J (1991) 1.32
Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol (Paris) (1974) 1.29
The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity. J Biol Chem (1987) 1.24
Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Relationship to synovitis mass and morning stiffness. Arthritis Rheum (1987) 1.23
Xanthine oxidoreductase is present in human synovium. Ann Rheum Dis (1987) 1.21
Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals. Ann Rheum Dis (1985) 1.19
Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin (1988) 1.17
Hyaluronate inhibition of cell proliferation. Arthritis Rheum (1987) 1.14
Free radicals in biological systems--a review orientated to inflammatory processes. Br Med Bull (1987) 1.07
Oxygen-radical production during inflammation may be limited by oxygen concentration. Biochem J (1984) 1.03
Characterization and identification of the hyaluronate binding site from membranes of SV-3T3 cells. J Biol Chem (1985) 1.03
Relationship between iron deposits and tissue damage in the synovium: an ultrastructural study. Ann Rheum Dis (1986) 1.02
Biochemistry of hyaluronan. Acta Otolaryngol Suppl (1987) 1.01
Hyaluronic acid enhances phagocytosis of human monocytes in vitro. J Clin Immunol (1984) 0.98
Synthesis of hyaluronate in cultured bovine articular cartilage. Biochem J (1989) 0.94
The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA). Free Radic Res Commun (1985) 0.94
Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol (1982) 0.93
[Clinical evaluation of sodium hyaluronate in the treatment of osteoarthritis of the knee]. Ryumachi (1983) 0.90
The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheumatol (1989) 0.87
Rheology of hyaluronate. Acta Otolaryngol Suppl (1987) 0.87
Release of hyaluronate from eukaryotic cells. Biochem J (1990) 0.87
Modulation of mitogen-dependent lymphocyte stimulation by hyaluronic acid. J Rheumatol (1984) 0.82
Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med (1992) 5.97
Human parvovirus arthropathy. Lancet (1985) 3.76
Self-poisoning: management of patients in Nottingham, 1976. Br Med J (1978) 3.24
Qualitative study of interpretation of reassurance among patients attending rheumatology clinics: "just a touch of arthritis, doctor?". BMJ (2000) 3.05
Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis (1992) 2.63
Simulating sensory-motor incongruence in healthy volunteers: implications for a cortical model of pain. Rheumatology (Oxford) (2005) 2.52
Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett (1998) 2.49
Renal impairment associated with non-steroidal anti-inflammatory drugs. Ann Rheum Dis (1987) 2.48
The importance of iron in rheumatoid disease. Lancet (1981) 2.44
The patient is not a blank sheet: lay beliefs and their relevance to patient education. Br J Rheumatol (1989) 2.42
Continuing worldwide increase in tropospheric methane, 1978 to 1987. Science (1988) 2.30
A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum (1991) 2.18
Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis. Ann Rheum Dis (1986) 2.12
Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut (1994) 2.10
A randomized, double-blind, placebo-controlled trial of sclerosing injections in patients with chronic low back pain. Rheumatology (Oxford) (1999) 2.09
Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum (1996) 2.07
Description of the analysis of a wide range of volatile organic compounds in whole air samples collected during PEM-tropics A and B. Anal Chem (2001) 2.07
Chromosome 22qII deletions. An under-recognised cause of idiopathic learning disability. Br J Psychiatry (1998) 2.03
Quality of life measures. Br J Rheumatol (1996) 1.97
Insulin and the production of acetone bodies by the perfused liver. J Physiol (1926) 1.96
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem (2000) 1.93
Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology (1992) 1.92
Joint stiffness in a phantom limb: evidence of central nervous system involvement in rheumatoid arthritis. Rheumatology (Oxford) (2003) 1.90
Organic aerosol formation downwind from the Deepwater Horizon oil spill. Science (2011) 1.89
Exercise induced release of von Willebrand factor: evidence for hypoxic reperfusion microvascular injury in rheumatoid arthritis. Ann Rheum Dis (1992) 1.77
The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett (1987) 1.77
Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in-vivo demonstration of iron-promoted oxidant stress. Lancet (1987) 1.69
A neurogenic mechanism for symmetrical arthritis. Lancet (1989) 1.69
A cyclin-dependent kinase-activating kinase (CAK) in budding yeast unrelated to vertebrate CAK. Science (1996) 1.68
Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull (1995) 1.65
Cdc37 is required for association of the protein kinase Cdc28 with G1 and mitotic cyclins. Proc Natl Acad Sci U S A (1995) 1.62
Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis (1991) 1.61
Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum (1987) 1.60
Identification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst (1994) 1.56
Role of aluminum in dialysis dementia. Ann Intern Med (1978) 1.56
Randomized placebo-controlled trial of brisk walking in the prevention of postmenopausal osteoporosis. Age Ageing (1997) 1.52
Effect of a specific iron chelating agent on animal models of inflammation. Ann Rheum Dis (1983) 1.52
Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol (1998) 1.51
Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. J Clin Invest (1985) 1.51
Methods for the measurement of hydroxyl radicals in biomedical systems: deoxyribose degradation and aromatic hydroxylation. Methods Biochem Anal (1988) 1.50
Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids. Biochem J (1986) 1.50
Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience (1990) 1.49
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1981) 1.48
Is chronic synovitis an example of reperfusion injury? Ann Rheum Dis (1986) 1.45
Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann Rheum Dis (1993) 1.45
Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Commun (1998) 1.42
Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene (1997) 1.42
Isolation and analysis of cDNAs encoding tomato cysteine proteases expressed during leaf senescence. Plant Mol Biol (1996) 1.41
Pain in the rheumatic diseases. Ann Rheum Dis (1997) 1.41
Effect of intravenous iron dextran on rheumatoid synovitis. Ann Rheum Dis (1985) 1.41
Use of Sulfuric Acid-Dichromate Mixture in Cleaning Glassware. Science (1946) 1.40
Photosynthetic control of atmospheric carbonyl sulfide during the growing season. Science (2008) 1.40
Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status. Ann Rheum Dis (1989) 1.40
Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut (1996) 1.39
Measuring outcome in rheumatoid arthritis--which measures are suitable for routine clinical use? Br J Rheumatol (1996) 1.39
Tooth-whitening activity of a novel home-bleaching system utilising thermal diffusion: a multifactorial simultaneous evaluation of efficacy at cervical, body and incisal tooth sites. Br Dent J (2012) 1.39
Cortical origins of pathological pain. Lancet (2000) 1.39
Cak1 is required for Kin28 phosphorylation and activation in vivo. Mol Cell Biol (1998) 1.39
RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia. Leukemia (1995) 1.39
A controlled pilot study of the utility of mirror visual feedback in the treatment of complex regional pain syndrome (type 1). Rheumatology (Oxford) (2003) 1.38
Open access to spirometry with chest x-ray. Br J Gen Pract (1990) 1.38
Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut (1992) 1.36
Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett (1987) 1.34
The buffering of muscle in rigor; protein, phosphate and carnosine. J Physiol (1938) 1.33
Oxidants, inflammation, and anti-inflammatory drugs. FASEB J (1988) 1.32
Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem J (1991) 1.32
The specificity of thiourea, dimethylthiourea and dimethyl sulphoxide as scavengers of hydroxyl radicals. Their protection of alpha 1-antiproteinase against inactivation by hypochlorous acid. Biochem J (1987) 1.32
Human T-cell tumours containing chromosome 14 inversion or translocation with breakpoints proximal to immunoglobulin joining regions at 14q32. EMBO J (1987) 1.32
Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull (1993) 1.30
Exhaled methyl nitrate as a noninvasive marker of hyperglycemia in type 1 diabetes. Proc Natl Acad Sci U S A (2007) 1.28
Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int (2006) 1.28
Changes in elasticity of mammalian muscle undergoing rigor mortis. J Physiol (1939) 1.25
Neurogenic influences in arthritis. Ann Rheum Dis (1990) 1.23
Cobalt(II) ion as a promoter of hydroxyl radical and possible 'crypto-hydroxyl' radical formation under physiological conditions. Differential effects of hydroxyl radical scavengers. Biochim Biophys Acta (1985) 1.22
Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed) (1986) 1.22
Cerebral and ocular toxicity induced by desferrioxamine. Q J Med (1985) 1.21
Xanthine oxidoreductase is present in human synovium. Ann Rheum Dis (1987) 1.21
The effect of synovial iron on the progression of rheumatoid disease. A histologic assessment of patients with early rheumatoid synovitis. Arthritis Rheum (1984) 1.20
Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun (1992) 1.19
Hypoxia and inflammatory synovitis: observations and speculation. Ann Rheum Dis (1991) 1.19
Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid. Implications for antioxidant protection in the inflamed rheumatoid joint. FEBS Lett (1987) 1.19
Estrogen receptor (alpha and beta) expression in the excurrent ducts of the adult male rat reproductive tract. J Androl (1998) 1.17
Human xanthine oxidase converts nitrite ions into nitric oxide (NO). Biochem Soc Trans (1997) 1.17
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Assessment of iron stores in inflammation by assay of serum ferritin concentrations. Br Med J (Clin Res Ed) (1981) 1.16
Synovial fluid ferritin in rheumatoid arthritis. Br Med J (1980) 1.14
Self-poisoning: psychiatric assessment by junior staff. Br Med J (1979) 1.13
Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis (1993) 1.12
Reactive oxygen species and iron--a dangerous partnership in inflammation. Int J Biochem Cell Biol (1995) 1.12
Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporos Int (2006) 1.11
The behaviour of caeruloplasmin in stored human extracellular fluids in relation to ferroxidase II activity, lipid peroxidation and phenanthroline-detectable copper. Biochem J (1985) 1.11
Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett (1992) 1.10
Cloning and characterization of tomato leaf senescence-related cDNAs. Plant Mol Biol (1997) 1.10
A new variant of chromosome 16. Hum Genet (1987) 1.09
The direct action of insulin on fat metabolism. J Physiol (1925) 1.09
Carotid disease in acute stroke. Age Ageing (1998) 1.09
Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis (2003) 1.09